{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Epoetin+alfa+once+weekly", "query": { "intervention": "Epoetin alfa once weekly" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 41, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Epoetin+alfa+once+weekly&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-01T05:17:00.374Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00077610", "title": "A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Anemia" ], "interventions": [ { "name": "Epoetin alfa or beta", "type": "DRUG" }, { "name": "RO0503821 (1x/2 Weeks)", "type": "DRUG" }, { "name": "RO0503821 (1x/4 Weeks)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 673, "start_date": "2004-02", "completion_date": "2005-08", "has_results": true, "last_update_posted_date": "2017-01-13", "last_synced_at": "2026-10-01T05:17:00.374Z", "location_count": 60, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Montgomery, Alabama + 51 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Encino", "state": "California" }, { "city": "Irvine", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00077610" }, { "nct_id": "NCT01975818", "title": "Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Anemia", "Renal Insufficiency, Chronic" ], "interventions": [ { "name": "Molidustat (BAY 85-3934)", "type": "DRUG" }, { "name": "Epoetin alfa/beta", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 201, "start_date": "2013-10-28", "completion_date": "2015-12-15", "has_results": false, "last_update_posted_date": "2019-09-20", "last_synced_at": "2026-10-01T05:17:00.374Z", "location_count": 30, "location_summary": "Azusa, California • Long Beach, California • Los Angeles, California + 21 more", "locations": [ { "city": "Azusa", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Lynwood", "state": "California" }, { "city": "Northridge", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01975818" }, { "nct_id": "NCT00454246", "title": "A Study of Mircera in Hemoglobin Control of Patients Transitioning to Dialysis.", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Anemia" ], "interventions": [ { "name": "methoxy polyethylene glycol-epoetin beta", "type": "DRUG" }, { "name": "epoetin alfa", "type": "DRUG" }, { "name": "darbepoetin alfa", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 111, "start_date": "2007-04", "completion_date": "2008-02", "has_results": true, "last_update_posted_date": "2011-12-16", "last_synced_at": "2026-10-01T05:17:00.374Z", "location_count": 78, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 75 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "El Dorado", "state": "Arkansas" }, { "city": "Hot Springs", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00454246" }, { "nct_id": "NCT00597753", "title": "Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Renal Failure", "Chronic Kidney Disease", "Anemia" ], "interventions": [ { "name": "peginesatide", "type": "DRUG" }, { "name": "Epoetin Alfa", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Affymax", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 803, "start_date": "2007-09", "completion_date": "2010-01", "has_results": true, "last_update_posted_date": "2013-02-12", "last_synced_at": "2026-10-01T05:17:00.374Z", "location_count": 89, "location_summary": "Paragould, Arkansas • Fairfield, California • Granada Hills, California + 76 more", "locations": [ { "city": "Paragould", "state": "Arkansas" }, { "city": "Fairfield", "state": "California" }, { "city": "Granada Hills", "state": "California" }, { "city": "Los Alamitos", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00597753" }, { "nct_id": "NCT00048048", "title": "A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Anemia" ], "interventions": [ { "name": "methoxy polyethylene glycol-epoetin beta [Mircera]", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 65, "start_date": "2002-03", "completion_date": "2004-11", "has_results": true, "last_update_posted_date": "2018-01-02", "last_synced_at": "2026-10-01T05:17:00.374Z", "location_count": 6, "location_summary": "Birmingham, Alabama • San Diego, California • Detroit, Michigan + 2 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Diego", "state": "California" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Las Vegas", "state": "Nevada" } ], "official_url": "https://clinicaltrials.gov/study/NCT00048048" }, { "nct_id": "NCT04313153", "title": "Trial Evaluating the Efficacy and Safety of Oral Vadadustat Once Daily (QD) and Three Times Weekly (TIW) for the Maintenance Treatment of Anemia in Hemodialysis Subjects Converting From Erythropoiesis-Stimulating Agents (ESAs)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Anemia" ], "interventions": [ { "name": "Vadadustat", "type": "DRUG" }, { "name": "Darbepoetin alfa", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Akebia Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 319, "start_date": "2020-05-27", "completion_date": "2022-06-22", "has_results": true, "last_update_posted_date": "2025-05-22", "last_synced_at": "2026-10-01T05:17:00.374Z", "location_count": 39, "location_summary": "Chula Vista, California • Granada Hills, California • Los Angeles, California + 31 more", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "Granada Hills", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Lynwood", "state": "California" }, { "city": "Northridge", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04313153" }, { "nct_id": "NCT05265325", "title": "A Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on Dialysis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Renal Anemia" ], "interventions": [ { "name": "AND017 capsules TIW", "type": "DRUG" }, { "name": "AND017 capsules QW", "type": "DRUG" }, { "name": "epoetin alfa, darbepoetin alfa, Mircera®, or their biosimilars", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kind Pharmaceuticals LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 175, "start_date": "2023-05-03", "completion_date": "2024-04-25", "has_results": false, "last_update_posted_date": "2024-06-28", "last_synced_at": "2026-10-01T05:17:00.374Z", "location_count": 10, "location_summary": "Pine Bluff, Arkansas • Riverside, California • Lone Tree, Colorado + 5 more", "locations": [ { "city": "Pine Bluff", "state": "Arkansas" }, { "city": "Riverside", "state": "California" }, { "city": "Lone Tree", "state": "Colorado" }, { "city": "Dalton", "state": "Georgia" }, { "city": "Gallup", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT05265325" }, { "nct_id": "NCT00258440", "title": "Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Anemia", "Fatigue", "Unspecified Adult Solid Tumor, Protocol Specific" ], "interventions": [ { "name": "Weekly procrit dosing", "type": "DRUG" }, { "name": "Interval Dosing", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "OHSU Knight Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 7, "start_date": "2003-05", "completion_date": "2008-09", "has_results": true, "last_update_posted_date": "2017-05-09", "last_synced_at": "2026-10-01T05:17:00.374Z", "location_count": 1, "location_summary": "Portland, Oregon", "locations": [ { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT00258440" }, { "nct_id": "NCT00003600", "title": "Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Anemia", "Breast Cancer", "Chronic Myeloproliferative Disorders", "Drug/Agent Toxicity by Tissue/Organ", "Leukemia", "Lung Cancer", "Lymphoma", "Multiple Myeloma and Plasma Cell Neoplasm", "Precancerous Condition", "Small Intestine Cancer", "Unspecified Adult Solid Tumor, Protocol Specific" ], "interventions": [ { "name": "epoetin alfa", "type": "BIOLOGICAL" }, { "name": "placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 344, "start_date": "1998-12", "completion_date": "2010-01", "has_results": false, "last_update_posted_date": "2016-07-13", "last_synced_at": "2026-10-01T05:17:00.374Z", "location_count": 20, "location_summary": "Scottsdale, Arizona • Washington D.C., District of Columbia • Peoria, Illinois + 17 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Peoria", "state": "Illinois" }, { "city": "Urbana", "state": "Illinois" }, { "city": "Cedar Rapids", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT00003600" }, { "nct_id": "NCT00752791", "title": "Efficacy and Safety of Peginesatide Injection for the Maintenance Treatment of Anemia in Peritoneal Dialysis Participants Previously Treated With Epoetin.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Anemia" ], "interventions": [ { "name": "Peginesatide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 59, "start_date": "2008-10", "completion_date": "2010-05", "has_results": true, "last_update_posted_date": "2012-08-15", "last_synced_at": "2026-10-01T05:17:00.374Z", "location_count": 19, "location_summary": "Azusa, California • Los Angeles, California • Whittier, California + 16 more", "locations": [ { "city": "Azusa", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Whittier", "state": "California" }, { "city": "Naples", "state": "Florida" }, { "city": "Decatur", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00752791" } ] }